Results 161 to 170 of about 44,030 (233)
The use of public spatial databases in risk analysis: A US‐oriented tutorial
Risk Analysis, EarlyView.Abstract This tutorial focuses on opportunities and challenges associated with using six large, publicly accessible spatial databases published during the last decade by US federal agencies. These databases provide opportunities for researchers to risk‐inform policy by comparing community asset, demographic, economic, and social data, along with ...
Michael R. Greenberg +2 more
wiley +1 more source
Transactions of the Institute of British Geographers, EarlyView.Abstract With the outbreak of COVID‐19, wastewater surveillance for public health rapidly emerged and expanded globally. In this article we chart the variegated ecosystem of private firms that work closely with public and non‐profit entities to transform metabolic flows of sewage into vital and valuable bioinformation, thereby creating new multi ...
Mohammed Rafi Arefin, Carolyn Prouse
wiley +1 more source
Mining an Anthropocene in Japan: On the making and work of geological imaginaries
Transactions of the Institute of British Geographers, EarlyView.Short Abstract This article addresses how the lithic and the drift might be reworked as an Anthropocene material outside of a chronostratigraphy. Revisiting the finding of a floating fern fossil at the Hashima mine, we delve into a complex array of Geological imaginaries, and undertake our own speculative work.
Deborah P. Dixon +2 more
wiley +1 more source
Industrial Policy and Domestic Value‐Added in Production and Exports: The Chinese Experience
The World Economy, EarlyView.ABSTRACT This paper studies the role of China's industrial policy in the evolving share of domestic value added (DVA) in its production and exports. We propose a method to quantify the DVA share in exports by extending. With national input–output tables and trade statistics from 2007 to 2020, we see a strong increase of the DVA share in exports and a ...
Kun Cai, Zhi Wang, Shang‐Jin Wei
wiley +1 more source
Veterinary Clinical Pathology, EarlyView.Abstract Artificial intelligence (AI) has transformative potential in veterinary pathology in tasks ranging from cell enumeration and cancer detection to prognosis forecasting, virtual staining techniques, and individually tailored treatment plans. Preclinical testing and validation of AI systems (AIS) are critical to ensure diagnostic safety, efficacy,
Christina Pacholec +3 more
wiley +1 more source
Cancer Cytopathology, Volume 133, Issue 7, July 2025.Abstract Background Medical technologies powered by artificial intelligence are quickly transforming into practical solutions by rapidly leveraging massive amounts of data processed via deep learning algorithms. There is a necessity to validate these innovative tools when integrated into clinical practice.
Esther Elishaev +10 more
wiley +1 more source
Clinical Pharmacology &Therapeutics, Volume 118, Issue 1, Page 95-105, July 2025.After a medicine has been tested in pivotal trials, regulators, health technology assessment (HTA) organizations, and professional societies make decisions about the patients best served by the medicine. This study assesses how the patient populations for oncology medicines (2010–2023) are defined (1) at trial, (2) regulatory submission, (3) upon ...
Milou A. Hogervorst +5 more
wiley +1 more source
Psychoneuroimmunological Evidence for Biological Embedding During Early Adolescence
Developmental Psychobiology, Volume 67, Issue 4, July 2025.ABSTRACT Adolescence is a period of vulnerability wherein stress can become biologically embedded in ways that impact long‐term trajectories of mental and physical health. In particular, stressors are transduced into physiological changes via the hypothalamic–pituitary–adrenal (HPA) axis in ways that can impact both physical and mental health. However,
Ellen Jopling +3 more
wiley +1 more source
An Expanded Access Protocol of RNS60 in Amyotrophic Lateral Sclerosis
Muscle &Nerve, Volume 72, Issue 1, Page 124-129, July 2025.ABSTRACT Aims RNS60 is an investigational product in clinical development for amyotrophic lateral sclerosis (ALS). RNS60 slowed disease progression in the ALS SOD1G93A mouse model and was safe and well tolerated both in an open‐label pilot study and a randomized, placebo‐controlled, multicenter phase 2 trial in people living with ALS.
Grace Addy +22 more
wiley +1 more source